Magellan Health, Inc. reaffirmed earnings guidance for the full year of 2020. The company is reaffirming its 2020 guidance ranges for revenue of between $4.4 billion to $4.6 billion, segment profit of between $145 million to $165 million. The company expects revenue and segment profit growth in 2021.